Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer

Author:

Cortés Javier123,Diéras Véronique45,Lorenzen Sylvie6,Montemurro Filippo7,Riera-Knorrenschild Jorge8,Thuss-Patience Peter9,Allegrini Giacomo10,De Laurentiis Michelino11,Lohrisch Caroline12,Oravcová Eva13,Perez-Garcia Jose M.2,Ricci Francesco5,Sakaeva Dina14,Serpanchy Rosanne12,Šufliarský Jozef1315,Vidal Maria316,Irahara Natsumi17,Wohlfarth Christine17,Aout Mounir1718,Gelmon Karen1219

Affiliation:

1. Quirónsalud Group, IOB Institute of Oncology, Madrid, Spain

2. Quirónsalud Group, IOB Institute of Oncology, Barcelona, Spain

3. Vall d’Hebron Institute of Oncology, Barcelona, Spain

4. Centre Eugène Marquis, Rennes, France

5. Institut Curie, Paris, France

6. Hematology/Medical Oncology, 3rd Department of Internal Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

7. Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy

8. Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps-Universität Marburg, Baldingerstraße, Marburg, Germany

9. Department of Haematology, Oncology and Tumorimmunology, Campus Virchow-Klinikum, Charité–University Medicine Berlin, Berlin, Germany

10. Division of Medical Oncology, Department of Oncology, Pontedera Hospital, Azienda L Toscana Nord Ovest, Pisa, Italy

11. Division of Breast Medical Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy

12. BC Cancer, Vancouver Cancer Centre, Vancouver, British Columbia, Canada

13. 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic

14. Department of Chemotherapy, Republican Clinical Oncology Center, Ufa, Russia

15. National Cancer Institute, Bratislava, Slovak Republic

16. Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, Barcelona, Spain

17. F. Hoffmann-La Roche Ltd, Basel, Switzerland

18. Now with Novartis, Basel, Switzerland

19. University of British Columbia, Vancouver, British Columbia, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3